Regenerative aesthetics uses collagen-stimulating treatments to improve skin quality from within, and whilst several options have solid clinical evidence, others remain promising but unproven.
- Regenerative aesthetics focuses on stimulating your skin’s own repair mechanisms rather than adding volume or relaxing muscles.
- Treatments with the strongest clinical evidence include polynucleotides, hyaluronic acid bio-remodelling injectables, calcium hydroxylapatite biostimulators, and Dermapen 4 microneedling.
- Emerging treatments such as exosome therapy and certain growth factor preparations show early promise but lack the long-term clinical data required to confirm safety and efficacy.
- Skin quality improvements from evidence-based regenerative treatments are typically gradual, cumulative, and require a personalised protocol rather than a single session.
- A careful assessment before any regenerative treatment is essential: the right choice depends on your skin quality, age, tissue laxity, and individual biological response.
Regenerative aesthetics refers to treatments that stimulate the skin’s own collagen and elastin production rather than simply filling or relaxing tissue. Evidence-based options include polynucleotides, hyaluronic acid skin boosters, calcium hydroxylapatite biostimulators, and medical-grade microneedling. Several newer modalities, including certain exosome therapies and growth factor serums, currently lack sufficient clinical data to support routine use.
Your skin produces less collagen every year from your mid-twenties onwards. By the time visible changes appear, that process has been quietly underway for a decade. Regenerative aesthetics exists precisely to address this: not by masking the signs of collagen loss, but by working with your skin’s own biology to slow and partially reverse it. The challenge is that the field is expanding faster than the evidence base, and distinguishing treatments with genuine clinical support from those riding a wave of marketing enthusiasm requires careful analysis.
Regenerative aesthetics refers to treatments that stimulate the skin’s own collagen and elastin production rather than simply filling or relaxing tissue. Evidence-based options include polynucleotides, hyaluronic acid skin boosters, calcium hydroxylapatite biostimulators, and medical-grade microneedling. Several newer modalities, including certain exosome therapies and growth factor serums, currently lack sufficient clinical data to support routine use.
This article maps the current evidence landscape honestly. It covers what is well-supported, what is promising but premature, and how a careful skin assessment helps determine which approach is right for your specific situation.
—
What is regenerative aesthetics and how does it differ from traditional aesthetic medicine?
The biological basis of collagen stimulation
Collagen and elastin are structural proteins produced by fibroblasts in the dermis. As you age, fibroblast activity slows, existing collagen fibres fragment, and the scaffolding that keeps skin firm and resilient gradually degrades. Environmental factors, particularly ultraviolet exposure, accelerate this process significantly in South Africa’s climate.
Traditional aesthetic medicine largely addressed these changes by working around them: adding volume with hyaluronic acid-based dermal fillers, relaxing movement with botulinum toxin, or resurfacing the skin’s outer layers. These approaches remain valuable, but they do not fundamentally alter the rate of collagen loss or stimulate new structural tissue.
Regenerative aesthetics takes a different route. Rather than compensating for collagen loss, regenerative treatments aim to stimulate fibroblast activity directly, prompting your skin to produce new collagen and elastin. The mechanism varies by treatment: some use biological signalling molecules, others trigger a controlled wound-healing response, and others introduce scaffolding that the body gradually replaces with its own tissue.
Why skin quality treatments have moved to the centre of aesthetic medicine
The shift towards skin quality as a primary treatment goal reflects both scientific progress and changing patient priorities. Research into the extracellular matrix, growth factor signalling, and the biology of skin ageing has produced a clearer picture of what drives visible change, and that understanding has translated into more targeted treatment options.
From a patient perspective, the appeal is intuitive. Treatments that improve your skin’s intrinsic quality produce changes that look genuinely natural, because they are natural. Improved hydration, firmer texture, and more even tone emerge gradually as your own biology responds to treatment, rather than appearing immediately as an external addition. For those who value subtle enhancement over obvious intervention, this is a meaningful distinction.
The diagnostic-first approach that guides practice at Dr Alek Nikolic reflects this shift. Understanding your skin’s current biological state, through tools such as VISIA skin analysis and detailed clinical assessment, is what allows a personalised regenerative protocol to be designed with precision rather than guesswork.
—
Which collagen-stimulating treatments have the strongest clinical evidence?
Polynucleotides: mechanism, evidence, and realistic expectations
Polynucleotides are fragments of purified DNA, typically derived from salmon or trout sperm, that act as biological signalling molecules when injected into the dermis. They bind to receptors on fibroblasts, stimulating proliferation and collagen synthesis, whilst also reducing oxidative stress in the local tissue environment.
The clinical evidence for polynucleotides in skin rejuvenation has grown substantially over the past decade. Studies indicate improvements in skin hydration, elasticity, and texture following a course of treatment, with a favourable safety profile across skin types. They are particularly well-suited to areas where delicate tissue quality is the primary concern, such as the under-eye area, neck, and décolletage.
Realistic expectations are important here. Polynucleotides improve skin quality progressively over a course of sessions; they do not produce immediate volumising effects. Most protocols involve two to three sessions spaced several weeks apart, with continued improvement as collagen remodelling progresses over the following months.
Hyaluronic acid skin boosters and bio-remodelling injectables
Hyaluronic acid skin boosters work differently from volumising dermal fillers. High-concentration hyaluronic acid formulations injected superficially into the dermis attract and retain water, improving hydration and stimulating fibroblasts to produce collagen and elastin through a process known as bio-remodelling of the extracellular matrix.
The evidence for this category is well-established, with multiple controlled studies demonstrating improvements in skin elasticity, hydration, and overall quality. Bio-remodelling injectables spread through the tissue rather than remaining localised, which means they address skin quality across a broader area rather than correcting a specific structural deficit.
These treatments suit a wide age range and are frequently used as a foundation within a regenerative protocol, particularly for those beginning to notice changes in skin texture and hydration rather than significant volume loss.
Calcium hydroxylapatite biostimulators: how they work and what the research shows
Calcium hydroxylapatite is a mineral compound that, when injected in a diluted formulation, acts as a biostimulator rather than a volumising filler. The microspheres trigger a controlled inflammatory response that stimulates fibroblast activity, leading to new collagen production over several months as the carrier gel is absorbed.
Clinical research supports its use for improving skin laxity, texture, and firmness, particularly in areas such as the face, neck, and hands. The collagen stimulation effect tends to be more pronounced and longer-lasting than that achieved with hyaluronic acid skin boosters alone, making it a useful option for those with more established skin laxity.
Medical-grade microneedling with Dermapen 4: the evidence for collagen induction therapy
Dermapen 4 microneedling creates controlled micro-injuries in the dermis using fine oscillating needles, initiating a wound-healing cascade that drives fibroblast activity and new collagen synthesis. The evidence base for collagen induction therapy is well-established across multiple indications, including skin texture, fine lines, enlarged pores, and acne scarring.
One relevant advantage for South African patients is its comparatively lower risk of post-inflammatory hyperpigmentation in darker skin tones compared to many energy-based devices. Dermapen 4 is frequently combined with topical bio-active preparations, including polynucleotides or growth factor serums, applied at the time of treatment to enhance tissue uptake and biological response.
—
What about poly-L-lactic acid and other longer-acting biostimulators?
Poly-L-lactic acid occupies a distinct position amongst regenerative treatments. It is a synthetic, biodegradable polymer that, when injected, stimulates a gradual fibroblastic response, producing new collagen over a period of months as the particles are slowly absorbed. Unlike immediate-effect fillers, the visible improvement from poly-L-lactic acid emerges progressively, which aligns well with the natural-enhancement philosophy central to regenerative aesthetics.
The clinical evidence for poly-L-lactic acid is well-established, with studies supporting its use for facial volume restoration and skin quality improvement in patients with significant collagen loss. It is typically administered in a series of sessions spaced several weeks apart, with the full effect becoming apparent over three to six months. The collagen stimulation it produces can persist for up to two years in some patients, making it one of the longer-lasting options in the biostimulator category.
Poly-L-lactic acid requires careful technique and precise dilution to minimise the risk of nodule formation, which underscores why practitioner training and experience with the product matter considerably. It is generally better suited to patients with established tissue laxity and volume loss rather than those seeking early preventative treatment, because its mechanism is most effective where there is meaningful collagen deficit to address.
Newer biostimulators are also entering the market, including polymerised hyaluronic acid formulations designed to provide both immediate hydration and longer-term collagen stimulation. The evidence base for these newer preparations is still accumulating, and whilst early clinical data is encouraging, it is not yet as robust as that supporting calcium hydroxylapatite or poly-L-lactic acid. A careful assessment of your skin’s specific needs, rather than defaulting to the newest available option, remains the most sensible approach to selecting a biostimulator.
For those considering longer-acting treatments, it is worth understanding that the gradual nature of the response requires patience. The absence of immediate visible change after a first session does not indicate that the treatment is not working; the biological process of collagen synthesis simply takes time to produce visible surface improvement.
—
Which regenerative treatments are still unproven or require more research?
Exosome therapy: early promise, limited long-term data
Exosomes are extracellular vesicles released by cells that carry signalling molecules, proteins, and genetic material. In regenerative medicine, they are being investigated for their potential to stimulate tissue repair, reduce inflammation, and trigger collagen synthesis. Early laboratory and small clinical studies have produced encouraging signals, and exosome-based preparations are increasingly available in aesthetic practice.
However, the evidence base remains at an early stage. Long-term safety data in aesthetic applications is limited, regulatory frameworks governing exosome products vary considerably across markets, and significant variation exists in product quality and manufacturing standards. At present, exosome therapy is better described as promising than proven, and a careful assessment is essential before considering it as part of any protocol.
Growth factor serums and platelet-rich plasma: separating evidence from enthusiasm
Platelet-rich plasma (PRP) involves concentrating growth factors from your own blood and reinjecting them to stimulate tissue repair and collagen production. The evidence for PRP in skin rejuvenation and hair restoration is growing, but study quality is inconsistent. Variability in preparation protocols, platelet concentrations, and outcome measures makes direct comparison across studies difficult, and the evidence does not yet match the volume or consistency supporting established biostimulators.
Topical growth factor serums present a different challenge: the molecular size of most growth factors limits their ability to penetrate intact skin meaningfully, which raises questions about the efficacy of topical application outside of procedures that disrupt the skin barrier, such as microneedling.
Stem cell treatments in aesthetics: what the science currently supports
The term “stem cell treatment” is used loosely in aesthetic marketing, often to describe products containing plant-derived stem cell extracts or conditioned media from cultured cells. True stem cell therapy in aesthetics remains largely experimental. The science is genuinely interesting, but clinical evidence in humans for aesthetic indications is sparse, and regulatory oversight is variable. Caution is warranted until the evidence base matures.
—
How do you know which regenerative treatment is right for your skin?
The role of a detailed skin assessment before any regenerative protocol
No regenerative treatment works equally well for every skin type, age, or concern. The right choice depends on your skin’s current quality, the degree of collagen loss present, your skin tone, your lifestyle factors, and how your tissue is likely to respond to different stimuli. This is why a detailed skin assessment before any treatment is not a formality; it is the foundation on which a rational personalised protocol is built.
At Dr Alek Nikolic’s practice, the assessment process includes a careful clinical examination of skin quality, laxity, texture, and tone, alongside a review of your skin history, previous treatments, and current skincare routine. This information shapes the choice of treatment category, the number of sessions required, and the sequencing of different modalities within a broader protocol.
How VISIA skin analysis informs treatment selection
VISIA skin analysis uses multispectral imaging to reveal features of your skin that are not visible under standard examination. It maps surface texture, pore characteristics, pigmentation, UV damage, and vascular features, providing an objective baseline against which the response to treatment can be measured over time.
For regenerative aesthetics specifically, VISIA is valuable because it can identify subsurface UV damage and early pigmentation changes before they become visible to the naked eye, guiding the timing and type of preventative treatment. It also allows for objective comparison at follow-up appointments, so that the response to a collagen-stimulating protocol can be assessed with evidence rather than impression alone.
—
What realistic improvement can you expect from regenerative aesthetics?
Regenerative aesthetics produces real, measurable improvement in skin quality, but the nature of that improvement is gradual and cumulative rather than immediate and dramatic. Setting accurate expectations is part of an honest consultation, and it is worth understanding what these treatments can and cannot achieve before committing to a protocol.
Skin boosters and polynucleotides typically produce noticeable improvements in hydration, radiance, and fine-line appearance over a course of two to three sessions, with continued improvement in the weeks following the final session as collagen remodelling progresses. Many patients describe their skin as looking healthier and more rested rather than obviously treated, which aligns with the enhancement-of-natural-features philosophy.
Biostimulators such as calcium hydroxylapatite and poly-L-lactic acid address more established laxity and volume loss, with improvements becoming apparent over three to six months. The collagen they stimulate is your own, so the outcome integrates naturally with your facial anatomy.
Dermapen 4 microneedling produces progressive improvement in texture, tone, and fine lines over a series of sessions, with the full benefit of each session continuing to develop for four to six weeks afterwards.
What regenerative treatments do not do is replace lost structural volume in the way that hyaluronic acid-based dermal fillers do, or relax dynamic lines in the way that botulinum toxin does. For many people, the most effective personalised protocol combines regenerative treatments with targeted use of these established modalities, addressing skin quality and structural concerns simultaneously.
Your individual response will vary depending on your skin’s starting point, your age, your sun protection habits, and your overall skin health. Maintenance sessions are a realistic part of any long-term regenerative approach, because collagen production continues to decline with age regardless of treatment.
—
Frequently asked questions about regenerative aesthetics and collagen stimulation
Q: What is the difference between a skin booster and a biostimulator?
Skin boosters are injectable treatments, typically hyaluronic acid-based, that hydrate the skin and improve its quality through bio-remodelling of the extracellular matrix. Biostimulators such as calcium hydroxylapatite or poly-L-lactic acid work differently: they trigger a controlled inflammatory response that stimulates your own fibroblasts to produce new collagen over several months. Both categories fall under regenerative aesthetics, but they act through distinct mechanisms and suit different skin concerns.
Q: How many sessions do I need to see a difference?
Most regenerative treatments require a course of sessions rather than a single appointment, because collagen remodelling is a biological process that takes time. Skin boosters are typically administered in a series of two to three sessions spaced three to four weeks apart, whilst biostimulators may show progressive improvement over three to six months following one or two treatment sessions. Your practitioner will design a personalised protocol based on your skin’s starting point and individual response.
Q: Is platelet-rich plasma an evidence-based treatment for skin quality?
Platelet-rich plasma has a growing body of research supporting its use for skin rejuvenation and hair restoration, but evidence quality varies considerably across studies. Inconsistencies in preparation protocols and outcome measures make direct comparison difficult. Clinical experience suggests PRP can improve skin texture and hydration in some individuals, but it is not yet supported by the same volume of controlled trial data as polynucleotides or established biostimulators.
Q: Are exosome treatments safe and clinically proven?
Exosome-based treatments represent one of the most actively researched areas in regenerative medicine, with early studies showing encouraging signals for skin repair and collagen stimulation. However, long-term safety data in aesthetic applications remains limited, regulatory frameworks are still evolving, and significant variation exists in product quality. At present, exosome therapy is considered promising rather than fully evidence-based, and a careful assessment is essential before considering it.
Q: Can regenerative aesthetics replace dermal fillers or botulinum toxin?
Regenerative treatments address skin quality, texture, hydration, and gradual collagen loss, which is a different concern from volume replacement or muscle relaxation. For many people, a well-designed personalised protocol will combine regenerative treatments with targeted use of hyaluronic acid-based dermal fillers or botulinum toxin, addressing multiple aspects of the ageing process simultaneously. Whether regenerative treatments alone are sufficient depends on your individual skin assessment findings and your specific concerns.
Q: How does Dermapen 4 microneedling stimulate collagen?
Dermapen 4 microneedling creates controlled micro-injuries in the skin using fine needles, triggering a wound-healing cascade that stimulates fibroblast activity and new collagen production. Clinical evidence supports its use for improving skin texture, tone, fine lines, acne scarring, and pore appearance. Compared to energy-based devices, it carries a lower risk of post-inflammatory hyperpigmentation in darker skin tones, which is a relevant consideration for many South African patients.
Q: At what age should I start thinking about collagen-stimulating treatments?
Collagen production begins to decline gradually from the mid-twenties, which means preventative regenerative treatments can be relevant earlier than many people expect. Rather than a fixed age threshold, the appropriate starting point depends on your skin quality assessment, lifestyle factors such as sun exposure, and your individual rate of skin change. VISIA skin analysis can identify subsurface changes that are not yet visible to the naked eye, helping to guide the timing of any preventative protocol.
Q: How long do the effects of regenerative treatments last?
Duration varies by treatment type and individual biological response. Hyaluronic acid skin boosters typically maintain their effect for six to twelve months. Calcium hydroxylapatite biostimulators may produce collagen stimulation effects lasting twelve to eighteen months in many patients. Poly-L-lactic acid treatments can produce longer-lasting collagen stimulation, with some patients maintaining improvement for up to two years. These are general ranges rather than guarantees, and your response will depend on your skin, lifestyle, and sun protection habits.
—
If you are considering regenerative aesthetics and want to understand which treatments are genuinely appropriate for your skin, the starting point is an in-depth assessment rather than a treatment decision. Book a consultation at Dr Alek Nikolic’s Cape Town practice to begin with a VISIA skin analysis and a personalised review of your skin health, ageing concerns, and realistic options. Visit dralek.co.za to learn more or to arrange your assessment.
